Department of Anesthesiology and Pain Medicine, University of Ulsan College of Medicine, Asan Medical Center, Songpa-gu, Seoul, 138-736, Korea.
Anesth Analg. 2011 Jun;112(6):1347-52. doi: 10.1213/ANE.0b013e318214b2b0. Epub 2011 May 5.
Although regional cerebral oxygen saturation (rSO₂) measurements can detect disturbances in cerebral oxygenation, their usefulness is limited in patients with hyperbilirubinemia. We examined the relationship between rSO₂ and other laboratory variables that may affect interpretation of low rSO₂ in awake patients with end-stage liver disease before liver transplantation surgery.
Before induction of general anesthesia, rSO₂ was measured in 164 patients with liver cirrhosis (Child class A/B/C = 19/41/104) and 8 with fulminant hepatic failure. Patients with West Haven hepatic encephalopathy of grade 3 or 4 were excluded. Relationships between rSO₂ and laboratory variables were evaluated by correlation and multivariate regression, and by receiver operating characteristic curve analysis.
Univariate analyses showed that rSO₂ (median 58.5%, range 15% to 82%) correlated with serum total bilirubin, hemoglobin (Hb), creatinine, sodium, and magnesium concentrations, and prothrombin time (P < 0.001 each), but not with serum concentrations of glucose, albumin, potassium, and ammonia. Multiple logistic regression analysis showed that only elevated total bilirubin (range 0.4 to 66 mg/dL; odds ratio [OR] = 1.31; 95% confidence interval [CI] = 1.18 to 1.45) and low Hb (range 5.3 to 15.7 g/dL; OR = 0.21; 95% CI = 0.11 to 0.43) were independently related to rSO₂ <50%. The optimum cutoff points for observing an rSO₂ < 50% were total bilirubin >7.2 mg/dL (sensitivity 89%, specificity 90%) and Hb <9.6 g/dL (sensitivity 70%, specificity 82%).
High total bilirubin and low Hb concentrations were independently associated with rSO₂ values below 50% in end-stage liver disease patients awaiting liver transplantation. The results of this study identify patients in whom a low rSO₂ may be an artifact rather than cerebral ischemia.
尽管区域性脑氧饱和度(rSO₂)测量可以检测脑氧合的变化,但在高胆红素血症患者中,其用途有限。我们检查了 rSO₂与其他实验室变量之间的关系,这些变量可能会影响清醒状态下终末期肝病患者在肝移植手术前 rSO₂的解读。
在全身麻醉诱导前,测量了 164 例肝硬化患者(Child 分级 A/B/C=19/41/104)和 8 例暴发性肝衰竭患者的 rSO₂。排除了 West Haven 肝性脑病 3 或 4 级的患者。通过相关性和多变量回归以及接收者操作特征曲线分析,评估 rSO₂与实验室变量之间的关系。
单变量分析显示,rSO₂(中位数 58.5%,范围 15%至 82%)与血清总胆红素、血红蛋白(Hb)、肌酐、钠和镁浓度以及凝血酶原时间相关(P<0.001),但与血清葡萄糖、白蛋白、钾和氨浓度无关。多变量逻辑回归分析显示,只有升高的总胆红素(范围 0.4 至 66 mg/dL;优势比[OR]=1.31;95%置信区间[CI]=1.18 至 1.45)和低 Hb(范围 5.3 至 15.7 g/dL;OR=0.21;95%CI=0.11 至 0.43)与 rSO₂<50%独立相关。观察 rSO₂<50%的最佳截断点为总胆红素>7.2 mg/dL(敏感性 89%,特异性 90%)和 Hb<9.6 g/dL(敏感性 70%,特异性 82%)。
高总胆红素和低 Hb 浓度与终末期肝病患者等待肝移植时 rSO₂值<50%独立相关。本研究结果确定了 rSO₂较低可能是人为假象而不是脑缺血的患者。